๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype

โœ Scribed by Li, Ning; Oberley, Terry D.; Oberley, Larry W.; Zhong, Weixiong


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
751 KB
Volume
35
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background:

Recent studies suggest that the gene for manganese superoxide dismutase (mnsod) is a candidate tumor-suppressor gene. the present study was designed to study the effect of overexpression of mnsod on cultured human prostate carcinoma cells.

Methods:

Du145 human prostate carcinoma cells were transfected with the cdna for manganese superoxide dismutase (mnsod), and two clones overexpressing mnsod activity were subsequently characterized by comparison with parental and plasmid control-transfected cells.

Results:

One clone overexpressing mnsod had no change in other antioxidant enzymes (aes) (nonadapted), while a second clone showed an increase in catalase activity (adapted). sensitivity of parental, plasmid control-transfected, and mnsod cdna-transfected cells to agents that generate oxidative stress correlated with ae profiles. both clones overexpressing mnsod activity showed increased reactive oxygen species levels under basal cell culture conditions. both clones overexpressing mnsod activity showed inhibition of cell growth in vitro and in vivo compared with parental and plasmid control-transfected cells. flow cytometry studies using mitochondrial-specific probes showed equal mitochondrial mass in all cell lines, but altered mitochondrial membrane potential in mnsod-overexpressing clones compared with parental or plasmid control-transfected cells.

Conclusions:

Our results suggest novel mechanisms by which mnsod overexpression may modulate the malignant phenotype, with potential applications in developing new therapies for prostate cancer.


๐Ÿ“œ SIMILAR VOLUMES


Anticarcinogenic effect of FTY720 in hum
โœ Sompol Permpongkosol; Jing-Ding Wang; Shiro Takahara; Kiyomi Matsumiya; Norio No ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 164 KB

## Abstract Despite the high frequency of prostate cancer, therapeutic options for advanced disease are limited to chemotherapy, radiation or hormonal therapy and eventually fail in all patients. Therefore, alternative approaches need to be developed. We previously reported that FTY720, a metabolit

Detrimental effect of cancer preventive
โœ Neehar Bhatia; Rajesh Agarwal ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 250 KB ๐Ÿ‘ 2 views

## Background: Targeting epigenetic events associated with autonomous growth of advanced prostate cancer (pca) is a practical approach for its control, prevention, and treatment. recently we showed that treatment of prostate carcinoma du145 cells with cancer preventive flavonoid silymarin at 100-20

Anticarcinogenic Effect of a Polyphenoli
โœ Chapla Agarwal; Yogesh Sharma; Rajesh Agarwal ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 238 KB ๐Ÿ‘ 2 views

There is an increasing interest in identifying potent cancer preventive and therapeutic agents against prostate cancer (PCA). In a recent study, we showed that a polyphenolic fraction isolated from grape seeds (hereafter referred to as GSP) that is substantially rich in antioxidant procyanidins exer

Growth-inhibitory effects of luteinizing
โœ Donatella Dondi; Roberta M. Moretti; Marina Montagnani Marelli; Graziella Prates ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 131 KB ๐Ÿ‘ 2 views

Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for